Your session is about to expire
← Back to Search
Device
DBS System for Tourette Syndrome
N/A
Waitlist Available
Led By Michael Okun, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 24 months post-surgery
Awards & highlights
Study Summary
This trial will test if a new treatment, deep brain stimulation (DBS), is effective and safe for treating Tourette Syndrome (TS).
Eligible Conditions
- Tourette Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 24 months post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 24 months post-surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlation between increase in gamma oscillations and improvement in TS symptomatology
Reduction in total tics on the YGTSS after 24 months as an effect of centromedian (CM) continuous DBS stimulation
Reduction in total tics on the Yale Global Tic Severity Scale (YGTSS) after 6 months as an effect of centromedian (CM) continuous DBS stimulation
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Deep Brain Stimulation (DBS)Experimental Treatment2 Interventions
Subjects' DBS surgical intervention requires implantation of a DBS system: two CM thalamic leads (one in each brain hemisphere), two ECOG strip leads (one in each brain hemisphere), and two neurostimulators implanted in the chest.
The ECOG strip lead is implanted into the brain to provide an interface through which stimulation can be delivered or activity of the brain can be monitored by the device, or observed by a clinician using a programmer.
Neurostimulator and leads system includes a programmer, which includes a wand and telemetry interface, and a patient remote control to check battery status and whether the device is on or off. The programmer is used to set up the device, including setup of stimulation and recording, as well as to retrieve data for subsequent review.
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,339 Previous Clinical Trials
717,345 Total Patients Enrolled
7 Trials studying Tourette Syndrome
132 Patients Enrolled for Tourette Syndrome
National Science FoundationUNKNOWN
1 Previous Clinical Trials
13 Total Patients Enrolled
MedtronicIndustry Sponsor
605 Previous Clinical Trials
828,226 Total Patients Enrolled
1 Trials studying Tourette Syndrome
5 Patients Enrolled for Tourette Syndrome
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this medical experiment currently in the process of enlisting participants?
"The information on clinicaltrials.gov reveals that, while it was initially published in May 2014 and updated most recently in December 2021, this medical trial is not actively recruiting patients at the moment. However, there are presently 1404 other trials open to enrollment nationwide."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger